Renovus Capital Partners, a Philadelphia area-based investment firm, has made a majority investment in ToxStrategies, a multidisciplinary scientific consulting firm.
ToxStrategies is focused on toxicology, epidemiology, exposure sciences, industrial hygiene and safety and regulatory compliance. According to Renovus, the partnership looks to establish ToxStrategies as a growth platform to expand its services, staff and geographic reach. With Renovus’ support, the company will work to leverage its reputation, knowledge base, customer relationships and regulatory and scientific experience to expand its existing client base and develop new end markets.
“We have been able to effectively navigate the rapid growth of the scientific consulting industry despite the increasingly complicated regulatory environment,” states Mark Harris, co-founder of ToxStrategies. “With Renovus’ investment, we believe ToxStrategies is positioned to make substantial new advances and be the market leader.”